Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Truveris

Explore full profile

Truveris is a technology company driving transparency, access and lower costs across the prescription drug ecosystem.

New York City, United StatesFounded 2009Health Tech & Medtech
Valuation $100–500M Latest valuation · 2026
Revenue $10–50M Latest reported FY
Headcount <100 Current team size
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Truveris and the history behind them.

At a glance

Founded
2009
Headquarters
New York City, United States
Sector
Health Tech & Medtech
Power Law
Colt$25–100M revenue

Latest news

Press, funding announcements and product moves mentioning Truveris.

See all news

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Tribeca Venture Partners

Series B and later4 investors entered at this stage

Employees mapped 94 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 18 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 6 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · New York City HQ
Book a demo for the full country breakdown
Web traffic by country
6.1K monthly visits
across markets
🇺🇸 United States82%
🇮🇳 India18%
Top 2 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Truveris on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Truveris on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.